This week’s special guest on the OIS Retina Podcast is David Esposito, CEO of ONL Therapeutics. A West Point graduate who served as a platoon leader in the first Gulf War, Esposito began his career in ophthalmology as a pharmaceutical sales rep for Merck. This led to several executive positions and eventually to building and scaling private companies. His career came full circle when investors recruited him to ONL Therapeutics a year ago. In this episode, host Firas Rahhal, MD, digs into ONL’s portfolio of therapies in development, the latest on the company’s clinical trials, and how as a corporate leader Esposito draws on his military experience.